MYSTERIOUS: What you need to know ahead of abbott laboratories earnings release - You Need To See This

Valued at a market cap of $217 billion, Abbott Laboratories (ABT) is a healthcare company that develops, manufactures, and sells a broad range of medical devices, diagnostics, nutrition products, and branded generic pharmaceuticals. The North Chicago, Illinois-based company is expected to announce its fiscal Q4 earnings for 2025 in the near future.  

Ahead of this event, analysts expect this healthcare company to report a profit of $1.50 per share, up 11.9% from $1.34 per share in the year-ago quarter. The company has met or surpassed Wall Street’s bottom-line estimates in each of the last four quarters. In Q3, ABT’s EPS of $1.30 came in line with the forecasted figure.